CYTE is a unique CRO powered by a global network of over 3,000 sites in 45 countries. Our online platform enables seamless collaboration between sites, sponsors, and study management. We also offer a suite of support services such as data analytics and medical writing to ensure your study gets across the line.
CYTE was established as the delivery arm of the Thrombosis Research Institute (TRI) in London. TRI has been conducting scientific, clinical and outcomes research in cardiovascular disease for over 30 years. CYTE now delivers these world-leading capabilities in partnership with sponsors around the world.
Company Details
- Employees
- 18
- Founded
- -
- Address
- London, England Sw3 6lr, Gb
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- cyteglobal.com
- Keywords
- Real World Evidence, Project Management, Clinical Monitoring, Data Management, Data Science & Stats, Medical Writing, Digital Health, Qualified Sites, Quality Assurance, Training & Events.
- HQ
- London, England
Cyte Global Questions
Cyte Global's website is cyteglobal.com
Cyte Global's LinkedIn profile is https://uk.linkedin.com/company/cyte-global
Cyte Global has
18 employees.
View email and phone details for 18
employees at Cyte Global.
Cyte Global's industry is
Hospitals and Health Care
Cyte Global's top competitors are
Compass Pathways,
K2 Healthventures,
Conduit Connect,
Julius Clinical,
Mereo Biopharma,
Dmc Healthcare,
Thrombosis Research Institute, London,
Airfinity Ltd,
Affimed,
Cocoon Biotech.
Cyte Global's categories are Hospitals and Health Care
Cyte Global's founding year is 2018
